Ekso Bionics Provides COVID-19 Business Update and Reports Preliminary First Quarter 2020 Financial Results
09 avr. 2020 16h01 HE
|
Ekso Bionics Holdings, Inc.
- Company Regains Nasdaq Listing Compliance - RICHMOND, Calif., April 09, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for...
Ekso Bionics® Announces Reverse Stock Split
24 mars 2020 16h00 HE
|
Ekso Bionics Holdings, Inc.
RICHMOND, Calif., March 24, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (the “Company”) (Nasdaq: EKSO), a leading developer of exoskeletons for medical and industrial use, today announced...
Ekso Bionics Reports Fourth Quarter and Year End 2019 Results
27 févr. 2020 16h05 HE
|
Ekso Bionics Holdings, Inc.
RICHMOND, Calif., Feb. 27, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today...
Ekso Bionics® Announces Collaboration with Kindred Healthcare to Pilot EksoNR in Long-Term Acute Care Hospitals
25 févr. 2020 08h00 HE
|
Ekso Bionics Holdings, Inc.
RICHMOND, Calif., Feb. 25, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), a leading developer of exoskeletons for medical and industrial use, today announced a collaboration...
Ekso Bionics® to Report Fourth Quarter and Full Year 2019 Financial Results on February 27, 2020
20 févr. 2020 08h00 HE
|
Ekso Bionics Holdings, Inc.
RICHMOND, Calif., Feb. 20, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that it...
Post Acute Medical (PAM) Accelerates Adoption of Exoskeleton Rehabilitation with Three Additional EksoNR Devices from Ekso Bionics®
19 févr. 2020 08h00 HE
|
Ekso Bionics Holdings, Inc.; Post Acute Medical, LLC
ENOLA, Penn. and RICHMOND, Calif., Feb. 19, 2020 (GLOBE NEWSWIRE) -- Post Acute Medical, LLC, (PAM), a system of inpatient rehabilitation hospitals, has acquired three additional EksoNR devices from...
Ekso Bionics® Releases its Upgraded EksoPulse Platform, Advanced Cloud-Based Analytics for Robotic Exoskeleton-Assisted Rehabilitation
06 févr. 2020 08h00 HE
|
Ekso Bionics Holdings, Inc.
RICHMOND, Calif., Feb. 06, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (NASDAQ: EKSO), a leading developer of robotic exoskeletons, today announced the worldwide launch of its upgraded...
Ekso Bionics Reports Preliminary Fourth Quarter and Full Year 2019 Financial Results; Company Achieves Record Fourth Quarter Revenue
10 janv. 2020 08h00 HE
|
Ekso Bionics Holdings, Inc.
RICHMOND, Calif., Jan. 10, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (NASDAQ: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced...
Ekso Bionics® baut den Vertrieb des EksoVest in Nordeuropa aus
27 déc. 2019 02h00 HE
|
Ekso Bionics Holdings, Inc.
RICHMOND, Kalifornien, Dec. 27, 2019 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (NASDAQ: EKSO), ein führender Entwickler von Exoskeletten für medizinische und industrielle Anwendungen, gab...
Ekso Bionics® udvider distributionen af EksoVest til Nordeuropa
27 déc. 2019 02h00 HE
|
Ekso Bionics Holdings, Inc.
RICHMOND, Californien, Dec. 27, 2019 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (NASDAQ: EKSO), der er en af de førende udvikler af eksoskeletter til medicinsk og industriel brug, annoncerede i...